Skip to main content

Think generics will lower the cost of chemo? Think again

By Forbes  
   January 14, 2019

Chemotherapy drugs have become ridiculously expensive. Many new drugs come to market costing more than $100,000 per patient for a full course of treatment. Often, patients have to pay a significant portion of these costs. For example, a 20% co-insurance rate, typical for basic Medicare coverage, leaves patients responsible for more than $20,000 of chemotherapy costs, an often crippling burden.

Full story


Get the latest on healthcare leadership in your inbox.